4
Changes in Ownership
Eton Pharmaceuticals, Inc. Filed Acc 0001437749-26-032240
Chief Business Officer sold 4,166 shares at $55.07 ($229,406)
- Chief Business Officer acquired 10,522 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Krempa David · Chief Business Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-02 | Exercise or conversion : show line 1 in the form | +10,522 | 47,547 | D | ||
| 2026-10-06 | Sale : show line 2 in the form | −4,166 | $55.07 | $229,406 | 43,381 | D |
| Open-market sales · 4,166 sh · avg $55.07 · $229,406 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-02 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −10,522 | 21,044 | D |
Loading xslF345X06/rdgdoc.xml…